Alkaloida business to Tanzania; poppyseed growers concerned

Food

Hungarian poppy seed growers are concerned about their business after Alkaloida, Hungary’s sole maker of morphine, will now be purchasing its feedstock from Tasmania, according to reports in Hungarian media today.

Poppy seed growers have not been officially informed in writing about the cancellation of their contracts to supply Alkaloida with feedstock to make morphine, according to Világgazdaság and other daily news outlets.

Hungarian farmers grow poppy seed on 13,000 hectares, according to the National Association of Poppy Seed Producers (MTOSz), and the country is one of the biggest producers of morphine in the world.

The association is appealing to the government for assistance in the matter, business daily Napi Gazdaság reported.

Alkaloida, a unit of Indian-owned ICN Magyarország, said early in January that it was halting production of active ingredients in Hungary but would continue to make medicines and packaging.
Alkaloida CEO Harin Mehta informed the council of Tiszavasvári, where the company is based, in December about the move. Mehta cited global market conditions as the main reason: Market prices of active agents, including morphine and its derivatives, are lower than production costs, which made production loss-making, according to a company statement on the move.

Alkaloida had net losses of $24 million on $24.2 million sales revenue in its previous business year ending at the end of March 2013. Revenue rose $7.6 million and losses were up $2.7 million from a year earlier.

 

ADVERTISEMENT

Századvég raises GDP forecast to 7.8% Analysis

Századvég raises GDP forecast to 7.8%

Opposition parties to begin PM candidate primaries Elections

Opposition parties to begin PM candidate primaries

New editor-in-chief at Betone Studio Appointments

New editor-in-chief at Betone Studio

Budapest leaders make public transport free for under-14s City

Budapest leaders make public transport free for under-14s

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.